APA (7th ed.) Citation

F, B., M, N., S, R., R, M., M, N., K, S., . . . M, M. (2022). Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 71(7-8), 887. https://doi.org/10.1007/s00011-022-01573-3

Chicago Style (17th ed.) Citation

F, Bouhtit, et al. "Bioscreening and Pre-clinical Evaluation of the Impact of Bioactive Molecules from Ptychotis Verticillata on the Multilineage Potential of Mesenchymal Stromal Cells Towards Immune- and Inflammation-mediated Diseases." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.] 71, no. 7-8 (2022): 887. https://doi.org/10.1007/s00011-022-01573-3.

MLA (9th ed.) Citation

F, Bouhtit, et al. "Bioscreening and Pre-clinical Evaluation of the Impact of Bioactive Molecules from Ptychotis Verticillata on the Multilineage Potential of Mesenchymal Stromal Cells Towards Immune- and Inflammation-mediated Diseases." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.], vol. 71, no. 7-8, 2022, p. 887, https://doi.org/10.1007/s00011-022-01573-3.